drugset / Trial / NCT02275299
Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is intended to evaluate the efficacy and safety of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in patients with active Rheumatoid Arthritis (RA).
Timeline
- Start
- 2013-09
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iguratimod | Small molecule | 50 mg | Oral |
| Comparator | Leflunomide | Small molecule | 20 mg | Oral |
| Background | Methotrexate | Small molecule | 10 mg | Oral |